CAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.147600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.351800E-01
Normal-vs-Stage2
9.425800E-01
Normal-vs-Stage3
5.208600E-01
Normal-vs-Stage4
3.174400E-01
Stage1-vs-Stage2
8.816600E-01
Stage1-vs-Stage3
4.834600E-01
Stage1-vs-Stage4
5.640200E-01
Stage2-vs-Stage3
1.750390E-01
Stage2-vs-Stage4
5.221800E-01
Stage3-vs-Stage4
9.085600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.168800E-01
Normal-vs-AfricanAmerican
8.354200E-01
Normal-vs-Asian
8.877200E-01
Caucasian-vs-AfricanAmerican
9.716200E-01
Caucasian-vs-Asian
8.852400E-01
AfricanAmerican-vs-Asian
8.984000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.672600E-01
Normal-vs-Female
8.564400E-01
Male-vs-Female
5.456200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.590000E-01
Normal-vs-Age(41-60Yrs)
7.745400E-01
Normal-vs-Age(61-80Yrs)
9.351800E-01
Normal-vs-Age(81-100Yrs)
9.040400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.596500E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.680000E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.993600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.691800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.568800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.305200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.503000E-01
Normal-vs-Daily Drinker
3.696200E-02
Normal-vs-Weekly Drinker
6.833400E-01
Normal-vs-Occasional Drinker
8.258000E-01
Normal-vs-Social Drinker
7.149200E-01
Non Drinker-vs-Daily Drinker
2.502200E-02
Non Drinker-vs-Weekly Drinker
2.146600E-01
Non Drinker-vs-Occasional Drinker
3.018000E-01
Non Drinker-vs-Social Drinker
3.168800E-01
Daily Drinker-vs-Weekly Drinker
5.875500E-02
Daily Drinker-vs-Occasional Drinker
4.900200E-02
Daily Drinker-vs-Social Drinker
1.846590E-01
Weekly Drinker-vs-Occasional Drinker
6.709000E-01
Weekly Drinker-vs-Social Drinker
7.084600E-01
Occasional Drinker-vs-Social Drinker
5.398400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.556400E-01
Normal-vs-Grade 2
3.893800E-01
Normal-vs-Grade 3
1.602160E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.443600E-01
Grade 1-vs-Grade 3
2.337600E-01
Grade 1-vs-Grade 4
4.556400E-01
Grade 2-vs-Grade 3
7.287600E-02
Grade 2-vs-Grade 4
3.893800E-01
Grade 3-vs-Grade 4
1.602160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.930600E-01
Normal-vs-NonDiabetic
9.775800E-01
Diabetic-vs-NonDiabetic
6.771000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.859400E-01
Normal-vs-NoPancreatitis
9.846400E-01
Pancreatitis-vs-NoPancreatitis
4.647600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.585200E-01
Normal-vs-N1
9.306400E-01
N0-vs-N1
5.744800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.747000E-01
Normal-vs-TP53-NonMutant
7.591400E-01
TP53-Mutant-vs-TP53-NonMutant
3.897800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
